Results 31 to 40 of about 2,834 (225)
Rheumatology and Therapy, 2019 Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States.
Prashanth Sunkureddi +5 more
doaj +1 more source
Biological therapy in treatment of uveitis. Contemporary trends
Journal of Ophthalmology, 2017 Uveitis is a cause of blindness in about 10% of cases. According to many studies, TNF-? plays an important role in the development of uveitis. Anti-TNF-? are widely used in rheumatology and recently in ophthalmology.
A.V. Zborovskaia, A.E. Dorokhova
doaj +1 more source
Scotland Registry for Ankylosing Spondylitis (SIRAS) – Protocol [PDF]
, 2016 Funding SIRAS was funded by unrestricted grants from Pfizer and AbbVie. The project was reviewed by both companies, during the award process, for Scientific merit, to ensure that the design did not compromise patient safety, and to assess the global ...
Dean, Linda E +10 more
core +1 more source
Update in spondylarthropathy [PDF]
Arthritis Care & Research, 2004 Ankylosing spondylitis (AS) is the most common type of spondylarthropathy seen in clinical practice. Several reports have appeared in the past 2 years that have significantly advanced our understanding of the pathogenesis and treatment of this disease.
openaire +2 more sources
United European Gastroenterology Journal, Volume 8, Issue 10, Page 1196-1207, December 2020., 2020 Objective The purpose of this study was to investigate the impact of obesity on disease activity and disease outcome in patients with inflammatory bowel disease. Patients and methods The impact of obesity on inflammatory bowel disease disease activity and outcome was retrospectively assessed in 3075 patients enrolled in the prospective nation‐wide ...
Thomas Greuter +11 more
wiley +1 more source
Musculoskeletal Manifestations in Inflammatory Bowel Disease
Canadian Journal of Gastroenterology, 2001 Muscoloskeletal manifestations are the most common extraintestinal complications of inflammatory bowel disease. Wide ranges in prevalence have been reported, depending on the criteria used to define spondylarthropathy.
Giovanni Fornaciari +5 more
doaj +1 more source
Reactive arthritis: advances in diagnosis and treatment
Reumatismo, 2002 Reactive Arthritis (ReA) is an aseptic synovitis developing after a primary infection distant from the joint, mainly localized in the gastrointestinal (Enteroarthritis) or genitourinary tract (Uroarthritis).
C. Palazzi +6 more
doaj +1 more source
Disease activity in and quality of life of patients with psoriatic arthritis mutilans : the Nordic PAM Study [PDF]
, 2017 Objective: To describe the social status and health-related quality of life of patients with psoriatic arthritis mutilans (PAM) in the Nordic countries.Method: Patients with at least one mutilated joint confirmed by radiology were studied.
Ejstrup, L. +6 more
core +2 more sources
Arthritis &Rheumatology, Volume 72, Issue 11, Page 1855-1862, November 2020., 2020 Objective To investigate the relationship between smoking and imaging outcomes over 5 years in axial spondyloarthritis (SpA) and to assess whether socioeconomic factors influence these relationships. Methods Axial SpA patients from the Devenir des Spondylarthropathies Indifferérenciées Récentes cohort were included.
Elena Nikiphorou +5 more
wiley +1 more source
Persistent clinical efficacy and safety of anti-tumour necrosis factor \textgreeka therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response [PDF]
, 2008 Background: There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS).
Alten, R. +11 more
core +1 more source